Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates The following represents disclosure information provided by authors of this ...

The landscape shifted dramatically with the emergence of fam-trastuzumab deruxtecan-nxki (T-DXd), an ADC that combines trastuzumab with a potent topoisomerase I inhibitor payload, deruxtecan, via a ...

The NDA is based on results from the Phase III evERA Breast Cancer study. Credit: NMK-Studio / Shutterstock.com. (NMK-Studio / Shutterstock.com.) Roche has obtained acceptance from the US Food and ...

The U.S. Food and Drug Administration (FDA) on Tuesday approved a new, simplified monthly dosing schedule for Johnson & Johnson’s JNJ Rybrevant Faspro (amivantamab and hyaluronidase-lpuj). When ...

Epidermal growth factors (EGF) can fight wrinkles and dry skin similarly to retinol. Experts say EGFs can be an alternative to retinol for people with dry or sensitive skin. EGFs work by telling old ...

The approval was based on a cohort of treatment-naïve patients in the Beamion LUNG-1 trial who had unresectable or metastatic, non-squamous NSCLC with HER2 tyrosine kinase domain mutations.

Metastatic ILC shows significant biomarker heterogeneity, limiting single biopsy reliability and highlighting challenges in detection and monitoring.

Roche RHHBY announced that the FDA has accepted its new drug application (NDA) for giredestrant, an investigational oral therapy, in combination with everolimus, for the treatment of adult patients ...

Add Yahoo as a preferred source to see more of our stories on Google. When looking for products to mitigate the physical signs of aging, experts recommend adding a growth factor serum to your routine.